A cancer treatment that one experienced called the ‘most titillating thing I’ve seen in my lifetime’ just got approved The US Food and Drug Administration just approved a cutting-edge cancer therapy. On Wednesday, the FDA approved Novartis’ Kymriah, also known as tisagenlecleucel, a treatment for pediatric acute lymphoblastic leukemia. "I think this is the most arousing thing I’ve seen in…